( NYSE:VRX, Toronto:VRX )

News from Valeant Pharmaceuticals International, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 15, 2017, 08:00 ET Bausch + Lomb Helps To Recycle More Than One Million Units Of Contact Lens Materials Within First Year Of Launching The ONE By ONE Recycling Program

First Sponsored Contact Lens Recycling Program Collects More Than 7,000 lbs. of Waste Valeant Pharmaceuticals International, Inc.'s (NYSE:...


Nov 14, 2017, 16:10 ET Valeant Announces Pricing Of Private Offering Of Add-On Secured Notes

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") announced today that it has priced its previously...


Nov 14, 2017, 09:00 ET Ortho Dermatologics Announces Aspire Higher Scholarship Honorees

Scholarship Program Awards Students Across the Country Impacted by Dermatologic Conditions Ortho Dermatologics, a division of Valeant...


Nov 13, 2017, 07:35 ET Valeant Announces Launch of Private Offering of Add-On Secured Notes

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") announced today that it has launched an offering of...


Nov 10, 2017, 07:00 ET Valeant Pharmaceuticals Completes Sale of Obagi Medical Products Business to Haitong International Zhongua Finance Acquisition Fund I, L.P.

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant" or the "Company") today announced that it has completed the sale of...


Nov 08, 2017, 18:02 ET Valeant To Participate At The Stifel 2017 Healthcare Conference

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced that Joseph C. Papa, chairman and chief executive...


Nov 07, 2017, 07:00 ET Valeant Announces Third-Quarter 2017 Results

- Strong Third-Quarter 2017 Financial Results - Revenues of $2,219 million - GAAP Net Income of $1,301 million -...


Nov 06, 2017, 07:00 ET Valeant Agrees To Sell Sprout Pharmaceuticals Subsidiary To Former Shareholders Of Sprout Pharmaceuticals

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant" or the "Company") today announced that its affiliate has entered...


Nov 02, 2017, 16:05 ET Bausch + Lomb And Nicox Announce FDA Approval Of VYZULTA™ (Latanoprostene Bunod Ophthalmic Solution), 0.024%

Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bausch + Lomb, a leading global eye health company,...


Nov 02, 2017, 07:00 ET Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-118, Novel Plaque Psoriasis Treatment

Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that the U.S. Food and...


Oct 31, 2017, 07:00 ET Valeant Will Reduce Debt By Additional $125 Million

Valeant Will Exceed $5 Billion Debt Reduction Commitment, Achieving Milestone Earlier Than Anticipated Valeant Pharmaceuticals International,...


Oct 16, 2017, 20:34 ET Valeant And One Of Its Subsidiaries Announce Early Tender Results And Early Settlement Date For Cash Tender Offers For Senior Notes

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant") announced today the results to date of the pending cash tender...


Oct 12, 2017, 08:00 ET Ortho Dermatologics Announces Two-Year Findings From Pivotal Phase 3 Study Of SILIQ™ (brodalumab) Injection Data Demonstrating Long-Term Efficacy Profile

Data Sets Demonstrating Efficacy and Quality of Life Profile of SILIQ Presented at 2017 Fall Clinical Dermatology Conference Ortho...


Oct 04, 2017, 08:00 ET Solta Medical Receives FDA 510(k) Clearance for Thermage FLX™ System, Newest Generation Skin Smoothing Technology

New Thermage FLX™ System Reduces Treatment Time by 25 Percent and Enhances Patient Comfort Solta Medical, a division of Valeant...


Oct 03, 2017, 08:00 ET Bausch + Lomb Introduces Biotrue® ONEday for Astigmatism Contact Lenses in Europe

Bausch + Lomb, a leading global eye health company and division of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX)...


Oct 03, 2017, 07:00 ET Valeant Will Release Third-Quarter 2017 Financial Results On November 7

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") will release its third-quarter 2017 financial results on Tuesday,...


Oct 02, 2017, 19:47 ET Valeant Announces Pricing Of Private Offering Of Senior Secured Notes

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") announced today that it has priced its previously...


Oct 02, 2017, 07:36 ET Valeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1,000,000,000 Outstanding Principal Amount

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant") and Valeant Pharmaceuticals International ("VPI," and together with...


Oct 02, 2017, 07:35 ET Valeant Announces Launch Of Private Offering Of Senior Secured Notes

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") announced today that it has launched an offering of...


Sep 29, 2017, 07:00 ET Valeant Pharmaceuticals Completes Sale Of iNova Pharmaceuticals To Pacific Equity Partners And The Carlyle Group

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant" or the "Company") today announced that it has completed the sale of...


Sep 27, 2017, 21:22 ET Valeant Pharmaceuticals Provides Update On Canadian Regulatory Filing About Future Financing Plans

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant" or the "Company") routinely evaluates refinancing opportunities,...


Sep 27, 2017, 07:00 ET Valeant to Participate at the Deutsche Bank 25th Annual Leveraged Finance Conference

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced that Paul S. Herendeen, executive vice president,...


Sep 18, 2017, 07:00 ET Valeant To Participate At The Cantor Fitzgerald Global Healthcare Conference

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced that Paul S. Herendeen, executive vice president,...


Sep 15, 2017, 09:01 ET Valeant Commits $200,000 to Support Hurricane Relief Efforts

Donates More than $2 Million in Medicines and Health Care Products Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX)...


Sep 06, 2017, 07:00 ET Valeant To Participate At The Morgan Stanley Global Healthcare Conference

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced that Joseph C. Papa, chairman and chief executive...